Block 2 Flashcards

1
Q
A

Trigeminal Motor Nucleus in the rostral pons, the origin of the branchial motor fibers of CN V3, which innervate the muscles of mastication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
A

Solitary nucleus in the rostral medulla; the origin of the special (visceral) sensory fibers of CN VII (gustatory), which innervate the anterior 2/3 of the tongue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A

Facial motor nucleus, origin of the branchial motor (special visceral) fibers of CN VII that innervate all the muscles of facial expression, stapedius m., stylohyoid m., and posterior belly of the digastric m.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
A

Cochlear nucleus (CN 8)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Neuronopathy

A

pathology of sensory and/or motor neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Radiculopathy

A

pathology of nerve roots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

plexopathy

A

pathology of nerve plexus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

neuropathy

A

pathology of nerves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

myopathy

A

pathology of muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

polyneuropathy

A

pathology of multiple nerves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

axonopathy

A

polyneuropathy involving the nerve axon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

demyelinating neuropathy

A

polyneuropathy involving nerve myelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

mononeuropathy

A

pathology involving single nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

brain lesion

A

UMN signs; unilateral and contralateral to lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cord lesion

A

UMN signs: bilateral or unilateral, ipsilateral to lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

motor neuron lesion

A

UMN and LMN signs: diffuse and asymmetric, ipsilateral to lesion

17
Q

peripheral nerve lesion

A

LMN signs: symmetric, progress distal to proximal, ipsilateral to lesion

18
Q

NMJ lesion

A

Reflexes preserved. No atrophy at first. Fatiguable weakness. Proximal to distal distribution.

19
Q

Muscle lesion

A

Reflexes preserved. May have muscular atrophy. Weakness is not fatiguable. Proximal to distal distribution.

20
Q

Sxs of UMN lesion

A

Weakness, increased reflexes and increased tone (no atrophy or fasciculations

21
Q

Sxs of LMN lesion

A

Weakness, atrophy, fasciculations, and decreased reflexes & tone

22
Q

Lambert-Eaton Myasthenic Syndrome

A
  • Sxs: weakness, esp LE, fatiguability, may improve w/ exercise
  • automonic sxs: dry eyes, mouth, decreased sweating, constipation, and erectile dysfunction
  • bulbar/respiratory sxs are rare
  • Pathophys: Ab targeting Presynaptic voltage-gated Ca ch’s (and inhibition of Ca-dep release of ACh)
  • Labs: see **incremental **response and facilitation on EMG
  • Assoc. w/ small cell lung carcinoma
  • Lambert-Eaton Myasthenic Syndrome
  • Tx: 3,4 diaminopyridine or guanidine (increase ACh), AChE inhibitor, plasmaphoresis, or immunosuppression
23
Q

Acquired myasthenia gravis

A
  • clinical sxs: fatiguable weakness (extraocular, ptosis, bulbar, periph), fatigue, respiratory failure
  • Pathophys: auto-ab’s to postsynaptic ACh receptor or MuSK
  • Labs: **decremental **responseon EMG
  • Associated with thymic hyperplasia, thymomoas, and thymic carcinoma
  • Tx: AChE inhibitors (pyridostigime bromide), corticosteroids, IVIg, plasmapheresis, thymectomy
24
Q

Duchenne’s Muscular Dystrophy

A

Duchenne’s = Deleted Dystrophin

  • Onset in early childhood, pelvic-girdle weakness resulting in waddling gait; problems running/climbing, difficult getting up off floor
  • Enlarged calf muscles
  • Prognosis: stop walking in adolescence, dilated cardiomyopathy common cause of death
  • Pathophys: x-linked frameshift mt in dystrophin, a protein that serves as a structural link between cytoskeleton and ECM in skeletal muscle, localized to **sarcolemma membrane. **
  • Tx: steroids
25
Q

Becker Muscular Dystrophy

A

A less severe form of Duchenne’s MD; also x-linked mt of dystrophin, but usually non-frameshift insertions

26
Q

Limb Girdle Muscular Dystrophy 2B

A

proximal > distal weakness, calf-atrophy, onset in 20’s, recessive mt of chrom 2p13.2,

27
Q

Emery-Dreifuss Muscular Dystrophy

A
  • classic triad: progressive muscle weakness, jt contractures, and cardiac dz
  • inheritance: x-linked (emerin, FHL1), AD/ AR (lamin A/C)
  • prognosis: most remain ambulatory, need close cardiac f/u
28
Q

Fascioscapulohumeral muscular dystrophy

A
  • sxs: facial and shoulder girldle weakness; open eyes/mouth, shoulder sloped anteriorly rotated with **scapular winging **(dbl hump:
  • inheritance: AD decrease in # of D4Z4 repeats
  • prognosis: 20% wheel-chair bound
29
Q

Myotonic muscular dystrophy

A
  • AD trinucleotide repeat (CTG) leading to myotonia (onset 5-25 y.o), weakness, and myopathic facies
  • prognosis: slowly progressive muscular weakness, cardiac conduction defects

My Tonia, My Testicles (atrophy), My Toupee (frontal balding), My Ticker (arrhythmia)

30
Q

Dermatomyositis

A
  • an inflammatory myopathy with progressive proximal mu. weakness and classic derm signs of periorbital/nasal crease rash (heliotrope), “shawl sign,” grotton papules (edges of fingers)
  • Increased CK, increased risk for CA
  • Bx: perimysial inflammation (CD4 T cells) and atrophy
  • Tx: steroids long term
31
Q

Polymyositis

A
  • An inflammatory myopathy with progressive symmetric proximal muscle weakness, dysphasia, increased CK, increased risk for CA
  • Pathology: endomysial inflammation (CD8 T cells)
  • Tx: steroids
32
Q

Inclusion body myositis

A
  • Asymmetric weakness: quads, wrist/finger extensors, ankle dorsiflexors
  • Progressive over 5-20 yrs
  • Usually seen in older males
  • Pathology: atrophy/hyperstrophy, inflammation (rimmed vacuole within myofibril)
  • Tx: none effective
33
Q

Statin-associated AI myopathy

A
  • toxic myopathy associated with statin-use
  • increased CK, myalgias, most resolve with d/c use
  • Ab to HMGCR
  • Tx with immunosuppression
34
Q

Metabolic myopathy

A

Glycogen or lipid metabolism

clinical presentation: prox. muscle weakness, episodic sxs (often with exercise), rhabdomyolysis, muscle cramps

35
Q

Mitochondrial myopathies

A
  • clinical sxs: prox. muscle weakness, ext. ophthalmoplegia, seizures, ID, hearing loss
  • Mutation in DNA or nuclear-encoded mitochondrial enzyme complex component
  • Path: see increased mitochondria on bx “ragged-red fibers” on trichrome
36
Q
A